Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Market Data Solutions
Report an Issue
Market: Market:

Financial Technology & Market Data

 
No Matching Results
Advanced search
or
Menu

Codexis Inc (CDXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development GlobeNewswire - Wed Jul 11, 6:00AM CDT
CMTX - Wed Jul 11, 6:00AM CDT

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development....

CDXS : 15.90 (+0.95%)
Free Technical Research on Clovis Oncology and Three More Biotech Equities ACCESSWIRE - Mon Jul 9, 9:46AM CDT
CMTX - Mon Jul 9, 9:46AM CDT

Stock Research Monitor: CLSD, CDXS, and CHRS

CDXS : 15.90 (+0.95%)
CLSD : 10.00 (+0.10%)
CLVS : 47.87 (+1.76%)
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114 GlobeNewswire - Mon Jul 9, 7:00AM CDT
CMTX - Mon Jul 9, 7:00AM CDT

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with CDX-6114, its orally administered...

CDXS : 15.90 (+0.95%)
New Research Coverage Highlights WPP, Codexis, Natural Resource Partners LP, Mercer International, Booking, and SINOPEC Shangai Petrochemical -- Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire - Fri Jun 1, 7:00AM CDT
CMTX - Fri Jun 1, 7:00AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of WPP PLC (NYSE:WPP), Codexis,...

CDXS : 15.90 (+0.95%)
SHI : 61.75 (-0.98%)
WPP : 76.03 (+1.92%)
NRP : 31.95 (+0.63%)
MERC : 17.30 (-2.12%)
BKNG : 2,009.67 (-0.05%)
Codexis to Present at Three Upcoming Investment Conferences GlobeNewswire - Tue May 29, 6:00AM CDT
CMTX - Tue May 29, 6:00AM CDT

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences:

CDXS : 15.90 (+0.95%)
Cimpress Aims to Mitigate Risks by Decentralizing Operations Zacks Equity Research - Zacks Investment Research - Tue May 15, 10:09AM CDT
Zacks Equity Research - ZACKS - Tue May 15, 10:09AM CDT

Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.

CMPR : 150.92 (-0.26%)
CDXS : 15.90 (+0.95%)
KIGRY : 18.5200 (+3.99%)
HDS : 44.74 (-0.49%)
Here's Why You Should Add Sonoco (SON) to Your Portfolio Now Zacks Equity Research - Zacks Investment Research - Mon May 14, 8:17AM CDT
Zacks Equity Research - ZACKS - Mon May 14, 8:17AM CDT

Sonoco's (SON) prospects remain bright on the back of solid earnings estimate revision activity as well as an upbeat guidance.

SON : 56.45 (+2.21%)
CDXS : 15.90 (+0.95%)
AOS : 60.03 (-0.05%)
IEX : 140.04 (-0.45%)
Codexis Reports First Quarter 2018 Financial Results GlobeNewswire - Thu May 10, 3:06PM CDT
CMTX - Thu May 10, 3:06PM CDT

Total revenues increase 76% to $14.0 million on sharply higher R&D revenue

CDXS : 15.90 (+0.95%)
Porton Pharma Solutions and Codexis Launch Global Partnership BusinessWire - Mon Apr 23, 5:00AM CDT
CMTX - Mon Apr 23, 5:00AM CDT

Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis' world-leading biocatalyst technology within...

CDXS : 15.90 (+0.95%)
EnzymeWorks, Inc. Retracts Prior Press Release BusinessWire - Tue Apr 17, 6:48PM CDT
CMTX - Tue Apr 17, 6:48PM CDT

EnzymeWorks has been ordered by the United States District Court for the Northern District of California to retract its prior statements and press releases pertaining in any way to the settlement...

CDXS : 15.90 (+0.95%)
New Research Coverage Highlights Alliance Resource Partners, MyoKardia, Pan American Silver, Stitch Fix, Codexis, and Chemical Financial -- Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire - Mon Apr 9, 7:10AM CDT
CMTX - Mon Apr 9, 7:10AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alliance Resource Partners,...

CDXS : 15.90 (+0.95%)
SFIX : 34.38 (+0.38%)
PAAS : 16.52 (+0.92%)
ARLP : 19.10 (-0.52%)
MYOK : 56.80 (+2.07%)
CHFC : 56.19 (+0.12%)
Codexis Announces Pricing of Public Offering of Common Stock GlobeNewswire - Thu Apr 5, 8:16PM CDT
CMTX - Thu Apr 5, 8:16PM CDT

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of...

CDXS : 15.90 (+0.95%)
Codexis Announces Proposed Public Offering of Common Stock GlobeNewswire - Thu Apr 5, 3:02PM CDT
CMTX - Thu Apr 5, 3:02PM CDT

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in...

CDXS : 15.90 (+0.95%)
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco GlobeNewswire - Thu Apr 5, 6:00AM CDT
CMTX - Thu Apr 5, 6:00AM CDT

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 9:50 a.m....

CDXS : 15.90 (+0.95%)
Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer BusinessWire - Thu Mar 22, 8:00AM CDT
CMTX - Thu Mar 22, 8:00AM CDT

Origenis GmbH, a German biotech company specializing in the discovery and development of highly selective small molecule kinase inhibitors for CNS disorders, today announced the appointment...

CDXS : 15.90 (+0.95%)
XON : 14.75 (+0.55%)
Codexis, Inc. to Host Earnings Call ACCESSWIRE - Thu Mar 8, 11:46AM CST
CMTX - Thu Mar 8, 11:46AM CST

NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q4 Earnings Call to be held on March 8, 2018, at 4:30 PM Eastern Time.

CDXS : 15.90 (+0.95%)
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8 GlobeNewswire - Thu Mar 1, 6:01AM CST
CMTX - Thu Mar 1, 6:01AM CST

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after market close on Thursday, March 8, 2018. Codexis...

CDXS : 15.90 (+0.95%)
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization GlobeNewswire - Thu Feb 15, 6:01AM CST
CMTX - Thu Feb 15, 6:01AM CST

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director, Molecular Diagnostics. Codexis is expanding...

CDXS : 15.90 (+0.95%)
Codexis to Present at the 25th International Molecular Medicine Tri-Conference GlobeNewswire - Mon Feb 12, 6:00AM CST
CMTX - Mon Feb 12, 6:00AM CST

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved DNA ligase for the molecular diagnostics industry...

CDXS : 15.90 (+0.95%)
Codexis Reports Financial Results for the Third Quarter of 2017 GlobeNewswire - Thu Nov 9, 3:05PM CST
CMTX - Thu Nov 9, 3:05PM CST

Product sales increase 71% over the prior year

CDXS : 15.90 (+0.95%)
Please wait...

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
Thu Jun 21, 9:57AM CDT
EHC -0.38 , FTNT +0.53 , CAKE -0.45 , PLT -0.28 , AEO -0.65
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed the week with most contracts 3 to 4 cents higher on Friday. Nearby September was up 4.1% since last Friday, with higher closes every day this week. Solid exports and drier weather fueled some bottom picking and short covering acti...
Read More

1 hour ago

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot